載入...
Clinical outcomes and safety of apatinib monotherapy in the treatment of patients with advanced epithelial ovarian carcinoma who progressed after standard regimens and the analysis of the VEGFR2 polymorphism
The aims of the present study were to investigate the clinical outcomes and safety of apatinib monotherapy in the treatment of patients with advanced epithelial ovarian carcinoma (EOC) who have progressed after standard regimens, and to analyze the vascular endothelial growth factor receptor 2 (VEGF...
Na minha lista:
| 發表在: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7400731/ https://ncbi.nlm.nih.gov/pubmed/32782621 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.11857 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|